Calla Lily Clinical Care is a British medical device startup developing a leak-free, convenient and dosage-confident delivery platform for vaginally-delivered drugs. We are initially focused on delivering progesterone for miscarriage prevention and IVF, where there is an unmet need for a patient-friendlier means of drug administration during an already stressful fertility journey. Progesterone prescriptions have significantly increased following the Nov 2021 update to internationally-renowned NICE's guidance on miscarriages. Subsequent applications include treatments focused on menopause and on the vaginal microbiome. Our patented technology has received FDA clearance and was named one of TIME magazine’s Best Inventions of the Year.
Location: United Kingdom, England, London
Employees: 11-50
Total raised: $1.32M
Founded date: 2021
Investors 1
| Date | Name | Website |
| 28.02.2023 | Embryo Ven... | embryovent... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 03.04.2025 | - | $1.32M | - |
Mentions in press and media 3
| Date | Title | Description |
| 10.02.2026 | Calla Lily Clinical Care and Merck announce strategic collaboration to advance intravaginal drug delivery platform | Enhancing patient treatment experience and care with a new self-administered solution for vaginal therapeutics Versatile platform technology developed from a safe, award-winning, FDA-cleared medical device Strategic collaboration supporting... |
| 03.04.2025 | The Shadows of Cybercrime: How Cameroon's Web Developers Fuel Online Fraud | In the digital age, the internet is a double-edged sword. It connects us, but it also opens doors to deception. In Cameroon, a troubling trend has emerged. Web developers, skilled in technology, are inadvertently becoming the backbone of on... |
| 03.04.2025 | British medtech Calla Lily secures £1M for transformative progesterone delivery device | Calla Lily, a UK-based medtech who have created a device for pregnant women at risk of miscarriage has secured £1M in funding from the National Institute for Health and Care Research (NIHR). The device helps women undergoing early pregnancy... |